Possibilities for the therapeutic control of fibrosis.
D000447:Aldehydes / Q000378:metabolism; D000629:Aminopropionitrile / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D001847:Bone Diseases / Q000139:chemically induced; D002642:Chick Embryo; D003094:Collagen / Q000096:biosynthesis / Q000378:metabolism; D003240:Connective Tissue Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D007842:Lathyrism / Q000139:chemically induced; D011509:Proteoglycans / Q000378:metabolism; D051381:Rats; D012829:Silicosis / Q000517:prevention & control; D014945:Wound Healing
D000447:Aldehydes; D011509:Proteoglycans; C027243:beta-aminopropionitrile fumarate; D000629:Aminopropionitrile; D003094:Collagen